ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
56 hedge funds and large institutions have $16M invested in Aralez Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Holders
56
Holding in Top 10
–
Calls
$135K
Puts
$142K
Top Buyers
| 1 | +$498K | |
| 2 | +$425K | |
| 3 | +$261K | |
| 4 |
SM
Salzhauer Michael
|
+$171K |
| 5 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
+$150K |
Top Sellers
| 1 | -$2.27M | |
| 2 | -$284K | |
| 3 | -$260K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$197K |
| 5 |
D.E. Shaw & Co
New York
|
-$150K |